Immunotech inc stock
WitrynaThe 52-week low for AIM stock is $0.29. The current AIM stock price $0.4099 has increased 29.01% from its 52-week low. Witryna6 kwi 2024 · Complete AIM ImmunoTech Inc. stock information by Barron's. View real-time 0A4Y stock price and news, along with industry-best analysis.
Immunotech inc stock
Did you know?
Witryna11 kwi 2024 · A high-level overview of AIM ImmunoTech Inc. (AIM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. WitrynaAIM ImmunoTech Inc has a Value Score of 62, which is considered to be undervalued. When you look at AIM ImmunoTech Inc’s price-to-sales ratio at 150.42 compared to the industry median at 8.05, this company has a higher price relative to revenue compared to its peers. This could make AIM ImmunoTech Inc’s stock less attractive for value ...
Witryna11 kwi 2024 · Discover historical prices for AIM stock on Yahoo Finance. View daily, weekly or monthly formats back to when AIM ImmunoTech Inc. stock was issued. Home. Mail; News; Sport; Finance; Celebrity; Style; Weather; ... AIM ImmunoTech Inc. (AIM) NYSE American - NYSE American Delayed price. Currency in USD. Add to … Witryna2 dni temu · AIM ImmunoTech Inc. announced the appointment of W. Neal Burnette, Ph.D., as Chairman of its Scientific Advisory Board. Dr. Burnette is an experienced …
Witryna6 kwi 2024 · Of the 21 institutional investors that purchased AIM ImmunoTech stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Morgan Stanley ($1.51M), Renaissance Technologies LLC ($0.48M), BlackRock Inc. ($0.47M), State Street Corp ($0.17M), Dimensional Fund Advisors LP …
Witryna12 kwi 2024 · Company’s SAB is comprised of well-established leaders with expertise across biomedical research, academia, and pharmaceutical industry. OCALA, Fla., April 12, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and …
Witryna30 wrz 2024 · AIM ImmunoTech Inc (NYSE: AIM) has signed a Clinical Trial Agreement with hVIVO for Phase 2a Human Challenge Trial (HCT) for intranasal Ampligen as prophylaxis against respiratory viruses. The HCT ... hutterville south dakota incWitryna27 mar 2024 · AIM ImmunoTech Inc (AIM) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... AIM ImmunoTech Inc lowest stock price was $0.29 and its highest was $1.38 in the past 12 months. What is AIM ImmunoTech Inc’s market … mary taylor southport ncWitryna1 Aim Immunotech Inc (AIM) Stock's Price Graph & Average Annual Return Aim Immunotech Inc (AIM) 10-Year Price Chart: Below is a graph showing closing prices of Aim Immunotech Inc (AIM) for the past 10 years. The below chart uses adjusted close instead of market close prices. (Adjusted close factors in corporate or institutional … hutterville colony schoolWitrynaGet the latest Immunotech Laboratories, Inc. Common Stock (IMMB) real-time quote, historical performance, charts, and other financial information to help you make more … hutterville colony south dakotaWitryna12 kwi 2024 · AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. hutter tobiasWitryna11 kwi 2024 · Apr. 11, 2024, 08:09 AM. (RTTNews) - AIM ImmunoTech Inc. (AIM) on Monday said the early stage study evaluating its drug candidate Ampligen for the treatment of metastatic triple-negative breast ... hutter wholesale hardware denverWitryna25 mar 2024 · ImmunoTech (AIM) Message Board - Company Name: ImmunoTech, Stock Symbol: AIM, Industry: Biotechs - Total Posts: 2060 - Last Post: 02/26/2024 07:02:09 PM - company/specific stock … mary taylor previte